DE3888921D1 - Polypeptide. - Google Patents

Polypeptide.

Info

Publication number
DE3888921D1
DE3888921D1 DE88310094T DE3888921T DE3888921D1 DE 3888921 D1 DE3888921 D1 DE 3888921D1 DE 88310094 T DE88310094 T DE 88310094T DE 3888921 T DE3888921 T DE 3888921T DE 3888921 D1 DE3888921 D1 DE 3888921D1
Authority
DE
Germany
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88310094T
Other languages
English (en)
Other versions
DE3888921T2 (de
Inventor
Roger Camble
Ronald Cotton
Anand Swaroop Dutta
Christopher Frederick Hayward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878725598A external-priority patent/GB8725598D0/en
Priority claimed from GB888803478A external-priority patent/GB8803478D0/en
Priority claimed from GB888813355A external-priority patent/GB8813355D0/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of DE3888921D1 publication Critical patent/DE3888921D1/de
Publication of DE3888921T2 publication Critical patent/DE3888921T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE3888921T 1987-11-02 1988-10-27 Polypeptide. Expired - Fee Related DE3888921T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878725598A GB8725598D0 (en) 1987-11-02 1987-11-02 Polypeptides
GB888803478A GB8803478D0 (en) 1988-02-15 1988-02-15 Polypeptide compounds
GB888813355A GB8813355D0 (en) 1988-06-06 1988-06-06 Polypeptide compounds

Publications (2)

Publication Number Publication Date
DE3888921D1 true DE3888921D1 (de) 1994-05-11
DE3888921T2 DE3888921T2 (de) 1994-07-21

Family

ID=27263652

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3888921T Expired - Fee Related DE3888921T2 (de) 1987-11-02 1988-10-27 Polypeptide.

Country Status (8)

Country Link
US (1) US5068222A (de)
EP (1) EP0315367B1 (de)
JP (1) JPH01151599A (de)
AU (1) AU618029B2 (de)
DE (1) DE3888921T2 (de)
DK (1) DK610988A (de)
NZ (1) NZ226800A (de)
PT (1) PT88914B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
US4943561A (en) * 1988-11-28 1990-07-24 Merck & Co., Inc. Gastrin releasing peptide antagonist
GB2231051B (en) * 1989-05-05 1992-12-16 Erba Carlo Spa Bombesin antagonists
GB8913844D0 (en) * 1989-06-15 1989-08-02 Erba Carlo Spa Irreversible bombesin antagonists
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
ZA915740B (en) * 1990-07-26 1992-05-27 Merrell Dow Pharma Peptides
GB9016810D0 (en) * 1990-07-31 1990-09-12 Wellcome Found Peptides
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
US6083915A (en) * 1991-05-10 2000-07-04 Biomeasure, Inc. Method for treating liver cancer
WO1992020707A1 (en) * 1991-05-23 1992-11-26 Merrell Dow Pharmaceuticals Inc. Bombesin analogs
EP0626973A1 (de) * 1992-02-07 1994-12-07 Merrell Pharmaceuticals Inc. Phenylalanine derivate enthaltendes bombesin
IL106197A (en) * 1992-07-30 1999-11-30 Cor Therapeutics Inc Agagonists for the rhombin receptors and pharmaceutical preparations containing them
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
ES2297832T3 (es) * 1994-08-19 2008-05-01 La Region Wallonne Conjugados que comprenden un agente antitumoral y su utilizacion.
US6989371B1 (en) 1996-08-16 2006-01-24 Dabur Research Foundation Bombesin analogs for treatment of cancer
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
CA2405704C (en) * 2000-02-24 2010-11-16 Dabur Research Foundation Bombesin analogs for treatment of cancer
US6905765B2 (en) 2002-08-09 2005-06-14 E.I. Du Pont De Nemours And Company Polyether ester elastomers comprising poly(trimethylene-ethylene ether) ester soft segment and alkylene ester hard segment
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) * 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
EP1583564B1 (de) * 2003-01-13 2009-07-01 Bracco Imaging S.p.A Verbesserte linker für radiopharmazeutische verbindungen
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos
JPS5291839A (en) * 1976-01-26 1977-08-02 Wellcome Found Peptide and derivatives
US4332661A (en) * 1980-11-05 1982-06-01 Olin Corporation Cells having gasket lubricating means
AU549053B2 (en) * 1981-12-28 1986-01-09 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
EP0313158A3 (de) * 1987-10-23 1990-08-22 Merck & Co. Inc. Antagonisten von Gastrin freisetzenden Peptiden
US4958085A (en) * 1987-10-30 1990-09-18 Canon Kabushiki Kaisha Scanning circuit outputting scanning pulse signals of two or more phases
GB8808768D0 (en) * 1988-04-14 1988-05-18 Erba Carlo Spa Peptide ligands for bombesin receptors
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
AU638423B2 (en) * 1988-10-14 1993-07-01 The Administrators Of The Tulane Eductional Fund Therapeutic peptides
US4943561A (en) * 1988-11-28 1990-07-24 Merck & Co., Inc. Gastrin releasing peptide antagonist
GB8913844D0 (en) * 1989-06-15 1989-08-02 Erba Carlo Spa Irreversible bombesin antagonists

Also Published As

Publication number Publication date
US5068222A (en) 1991-11-26
NZ226800A (en) 1991-08-27
JPH01151599A (ja) 1989-06-14
PT88914B (pt) 1993-01-29
DE3888921T2 (de) 1994-07-21
DK610988A (da) 1989-05-03
EP0315367A2 (de) 1989-05-10
DK610988D0 (da) 1988-11-02
EP0315367A3 (en) 1990-11-28
AU2414288A (en) 1989-05-04
PT88914A (pt) 1988-12-01
EP0315367B1 (de) 1994-04-06
AU618029B2 (en) 1991-12-12

Similar Documents

Publication Publication Date Title
DE3888921D1 (de) Polypeptide.
FI892714A0 (fi) Rekombinant-coccidiosisvaccin.
DE3788626D1 (de) Nor-Statin und Nor-Cyclostatin enthaltende Polypeptide.
DK97790D0 (da) Renin-inhiberende peptider
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
NO881658L (no) Biofunksjonelle proteiner.
NO892294D0 (no) Polypeptidforbindelser.
DE68908633D1 (de) Polypeptide mit zellenverstreuender Aktivität.
DK353788D0 (da) Polypeptidderivater
NO881384D0 (no) Peptider.
NO885108D0 (no) Peptider.
DK551287A (da) Polypeptid
DK354389D0 (da) Polypeptid
ATE63462T1 (de) Vakzinale polypeptide.
NO890174D0 (no) Rekombinante interleukin-1alfa-polypeptider.
FI851488A0 (fi) Peptider.
DK492588A (da) Merozoit-antigen polypeptider
IT8721892A0 (it) Polipeptidi sequenziali immunologicamente attivi.
NO872386D0 (no) Peptider.
DK525787D0 (da) Polypeptidantagonister
DK624089D0 (da) Polypeptidforbindelser
DK341687D0 (da) Polypeptider
ATE58740T1 (de) Polypeptide.
DK596888A (da) Rekombinant lymfotoksin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee